Cytokinetics | CYTK - Przychody Ze Sprzedaży





Obroty Zmiana Data
Acadia Pharmaceuticals USD 268.06M 15.94M 2026-03
Amgen USD 8.62B 1.28B 2026-03
Arca Biopharma 0 0 2025-03
Bayer EUR 13.41B 1.97B 2026-03
Biogen USD 2.25B 30M 2026-03
Brainstorm Cell Therapeutics 0 0 2025-03
Bristol-Myers Squibb USD 11.49B 1.01B 2026-03
Capricor Therapeutics USD 11.13M 8.87M 2024-12
Cytokinetics USD 19.35M 1.59M 2026-03
Eisai JPY 205.43B 14.51B 2026-03
Eli Lilly USD 19.8B 500M 2026-03
Exelixis USD 610.8M 12.14M 2026-03
Geron USD 51.84M 3.82M 2026-03
Halozyme Therapeutics USD 377M 74.76M 2026-03
Ionis Pharmaceuticals USD 246M 43M 2026-03
Ligand Pharmaceuticals USD 51.72M 7.94M 2026-03
Merck USD 16.29B 110M 2026-03
Novartis USD 13.11B 226M 2026-03
Pfizer USD 14.5B 3.08B 2026-03
Regeneron Pharmaceuticals USD 3.6B 280M 2026-03
Roche Holding CHF 15.65B 274.5M 2025-12
Sanofi EUR 11.24B 60M 2026-03